Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Institutional investors holding positions in Boston Scientific Corporation (NYSE: BSX) during the period from July 23, 2025, through February 3, 2026,...
-
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP reminds purchasers of Gossamer Bio, Inc. (NASDAQ: GOSS) securities of a pending securities class action. THE CASE: A class...
-
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- On September 17, 2025, monday.com Ltd. (NASDAQ: MNDY) told investors the Company would reach $1.8 billion in revenue by fiscal year 2027. Less than five...
-
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- "Companies that make specific promises to investors about future performance have an obligation to disclose known risks to those projections. The...
-
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP encourages investors who suffered losses in PayPal Holdings, Inc. (NASDAQ: PYPL) to contact the firm. Those who purchased PYPL...
-
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP reminds purchasers of Camping World Holdings, Inc. (NYSE: CWH) securities of a pending securities class action. THE CASE: A...
-
Key Dates and Disclosure Events Shareholders Need to Know NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP encourages investors who suffered losses in Gemini Space Station,...
-
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Institutional investors holding positions in Soleno Therapeutics, Inc. (NASDAQ: SLNO) during the period March 26, 2025 through November 4, 2025 may wish...
-
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Corcept Therapeutics Incorporated ("Corcept Therapeutics Incorporated" or the "Company") (NASDAQ: CORT)...
-
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Institutional investors holding positions in Nektar Therapeutics (NASDAQ: NKTR) during the period from February 26, 2025 through December 15, 2025 may...